Page last updated: 2024-11-02

pipobroman and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

pipobroman has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Orlandi, E1
Bernasconi, P1
Boni, M1
Calatroni, S1
Lazzarino, M1
Tefferi, A1

Other Studies

2 other studies available for pipobroman and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
    Annals of hematology, 2005, Volume: 84, Issue:2

    Topics: Aged; Antineoplastic Agents, Alkylating; Cytogenetic Analysis; Female; Fusion Proteins, bcr-abl; Hum

2005
Is hydroxyurea leukemogenic in essential thrombocythemia?
    Blood, 1998, Aug-15, Volume: 92, Issue:4

    Topics: Acute Disease; Antineoplastic Agents, Alkylating; Bone Marrow; Busulfan; Chromosome Aberrations; Chr

1998